FibroGen, Inc. (FGEN)
8.77
-0.01
(-0.11%)
USD |
NASDAQ |
Dec 30, 12:51
FibroGen EPS Diluted (Quarterly): 36.71 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Skye Bioscience, Inc. | -0.3216 |
| Theravance Biopharma, Inc. | 0.0696 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.15M |
| Revenue (Quarterly) | 1.076M |
| Total Expenses (Quarterly) | 14.22M |
| Enterprise Value | -26.94M |
| Gross Profit Margin (Quarterly) | 87.55% |
| Profit Margin (Quarterly) | -1.22K% |
| Earnings Yield | 448.6% |
| Normalized Earnings Yield | 464.19 |